Common use of Notification and Split Sampling Clause in Contracts

Notification and Split Sampling. The MRO will notify each employee who has a verified positive test that the employee has seventy-two (72) hours within which to request a test of the split specimen. If the employee requests an analysis of the split specimen, the MRO will direct the laboratory, in writing, to ship the split specimen to another DHHS laboratory for analysis. An employee may also request an analysis of the split specimen for any specimen deemed to have been adulterated or substituted. If the analysis of the split specimen fails to confirm the presence of the drug(s), drug metabolite(s), or evidence of adulteration or substitution, found in the primary specimen, or if the split specimen is unavailable or inadequate for testing, the MRO will cancel the test and report the cancellation and the reasons for it to the DOT, the employer, and the employee. If the employee has not contacted the MRO within seventy-two (72) hours of being notified of a verified positive drug test or evidence of adulteration or substitution, the employee may present to the MRO information documenting that serious illness, injury, inability to contact the MRO, lack of actual notice of the verified positive test or evidence of adulteration or substitution, or other unavoidable circumstances that prevented the employee from contacting the MRO in time. If the MRO concludes that there is a legitimate explanation for the employee’s failure to contact the MRO, the MRO will direct that an analysis of the split sample be performed. If the MRO concludes that there is no legitimate explanation, the MRO is not required to direct the analysis of the split specimen. If, after the MRO makes all reasonable efforts (and documents them), the MRO is unable to reach the individual directly, the MRO will contact a designated Pace representative who will direct the employee to contact the MRO as soon as possible. If, after making all reasonable efforts, the designated Pace representative is unable to contact the employee, Pace may place the employee on temporary unqualified status or medical leave. The MRO will report each verified test result to the person designated by Pace to receive the results. Reporting of a verified positive result or taking action required as a result of a positive drug test will not be delayed pending the split sampling analysis. The MRO will maintain all necessary records and send test result reports to Pace’s General Manager and Chief Operating Officer (or a designated representative), Pace’s drug and alcohol program manager. The MRO will also report all negative drug tests which indicate the urine was diluted. It is Pace policy to ensure that the retesting of employees is consistent and therefore require the immediate retesting for all negative pre-employment reasonable suspicion, return to duty and follow-up testing where results have indicated a diluted urine sample. Such re-collections will not be collected under direct observation, unless there is another basis for use of direct observation.

Notification and Split Sampling. The MRO will notify each employee who has a verified positive test that the employee has seventy-two (72) hours within which to request a test of the split specimen. If the employee requests an analysis of the split specimensplit, the MRO will direct the laboratory, in writing, to ship the split specimen to the Union-designated DHHS laboratory (or in the event a Union is not involved, another DHHS laboratory laboratory) for analysis. An employee may also request If an applicant requests an analysis of the split specimen, the MRO will direct laboratory, in writing, to ship the split specimen to another DHHS laboratory for any specimen deemed to have been adulterated or substitutedtesting at the applicant’s expense. If the analysis of the split specimen fails to confirm the presence of the drug(s), drug metabolite(s), or evidence of adulteration or substitution, found in the primary specimen, or if the split specimen is unavailable or inadequate for testing, the MRO will cancel the test and report the cancellation and the reasons for it to the DOT, the employer, and the employee. If the employee has not contacted the MRO within seventy-two (72) 72 hours of being notified of a verified positive drug test or evidence of adulteration or substitution, the employee may present to the MRO information documenting that serious illness, injury, inability to contact the MRO, lack of actual notice of the verified positive test or evidence of adulteration or substitution, or other unavoidable circumstances that prevented the employee from contacting the MRO in time. If the MRO concludes that there is a legitimate explanation for the employee’s failure to contact the MRO, the MRO will direct that an analysis of the split sample be performed. If the MRO concludes that there is no legitimate explanation, the MRO is not required to direct the analysis of the split specimen. The decision of the MRO not to direct analysis of the split sample shall be subject to the grievance-arbitration procedures contained in the collective bargaining agreement between Pace and the Union. If, after the MRO makes all reasonable efforts (and documents them), the MRO is unable to reach the individual directly, the MRO will contact a designated Pace representative who will direct the employee to contact the MRO as soon as possible. If, after making all reasonable efforts, the designated Pace representative is unable to contact the employee, Pace may place the employee on temporary unqualified status or medical leave. The MRO will report each verified test result to the person designated by Pace to receive the results. Reporting of a verified positive result or taking action required as a result of a positive drug test will not be delayed pending the split sampling analysis. The MRO will maintain all necessary records and send test result results reports to Pace’s General Manager and Chief Operating Officer Xxxx’x Deputy Executive Director, Revenue Services (or a designated representative), Pace’s Xxxx’x drug and alcohol program manager. The MRO will also report all negative drug tests which indicate the urine was diluted. It is Pace policy to ensure that the retesting of employees employee is consistent and therefore require the immediate retesting for all negative pre-employment employment, reasonable suspicion, return to duty and follow-up testing where results have indicated a diluted urine sample. Such re-collections will not be collected under direct observationobservations, unless there is another basis for use of direct observation.

Notification and Split Sampling. ‌ The MRO will notify each employee Sergeant who has a verified positive test that the employee Sergeant has seventy-two (72) hours within which to request a test of the split specimen. If the employee Sergeant requests an analysis of the split specimen, the MRO will direct the laboratory, in writing, to ship the split specimen to another DHHS the Union-designated qualified SAMSHA laboratory for analysis. An employee may also request an analysis of the split specimen for any specimen deemed to have been adulterated or substituted. • If the analysis of the split specimen fails to confirm the presence of the drug(s), ) or drug metabolite(s), or evidence of adulteration or substitution, ) found in the primary specimen, or if the split specimen is unavailable or inadequate for testing, the MRO will cancel the test and report the cancellation and the reasons for it to the DOT, the employer, Village and the employeeSergeant. If the employee Sergeant has not contacted the MRO within seventy-two (72) hours of being notified of a verified positive drug test or evidence of adulteration or substitutiontest, the employee Sergeant may present to the MRO information documenting that serious illness, injury, inability to contact the MRO, lack of actual notice of the verified positive test or evidence of adulteration or substitutiontest, or other unavoidable circumstances that prevented the employee Sergeant from contacting the MRO in time. If the MRO concludes that there is a legitimate explanation for the employeeSergeant’s failure to contact the MRO, the MRO will direct that an analysis of the split sample be performed. If the MRO concludes that there is no legitimate explanation, the MRO is not required to direct the analysis of the split specimen. If, after the MRO makes all reasonable efforts (and documents them), the MRO is unable to reach the individual Sergeant directly, the MRO will contact a designated Pace Department representative who will direct the employee Sergeant to contact the MRO as soon as possible. If, after making all reasonable efforts, the designated Pace Department representative is unable to contact the employeeSergeant, Pace the Sergeant may place the employee be placed on temporary unqualified status or medical leave. The MRO will report each verified test result to the person designated by Pace the Village to receive the results. Reporting of a verified positive result or taking action required as a result of a positive drug test will not be delayed pending the split sampling analysis. The MRO will maintain all necessary records and send test result reports to Pace’s General Manager and Chief Operating Officer (or a designated representative), Pace’s drug and alcohol program manager. The MRO will also report all negative drug tests which indicate the urine was diluted. It is Pace policy to ensure that the retesting of employees is consistent and therefore require the immediate retesting for all negative pre-employment reasonable suspicion, return to duty and follow-up testing where results have indicated a diluted urine sample. Such re-collections will not be collected under direct observation, unless there is another basis for use of direct observation.